PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma

Table 1 The primary antibodies used in the study

Antibody	Species	Targeted species	Dilution ratio	Supplier	Catalogue number
β-actin	M	H, M, R	1:1000	CST	3700
PCNA	Rbt	H, M, R	1:2000	PT	10,205–2-AP
Bax	M	H, M, R	1:1000	PT	60,267–1-Ig
Caspase 3	Rbt	H, M, R	1:1000	PT	19,677–1-AP
Caspase 9	M	H, M, R	1:1000	PT	66,169–1-Ig
HK2	Rbt	H, M, R	1:1000	PT	22,029–1-AP
PFKFB3	Rbt	H, M, R	1:1000	CST	13,123
PKM2	M	H, M, R	1:1000	PT	60,268–1-Ig
OXPHOS	M	H, M, R	1:250	MT	MS604
HIF-1α	Rbt	H	1:1000	PT	20,960–1-AP
HSP90	M	H, M, R	1:1000	PT	60,318–1-Ig
LaminA/C	R	H, M, R	1:1000	PT	10,298–1-AP
NF-κB	R	H, M, R	1:1000	PT	10,745–1-AP
Stat3	M	H, M, R	1:1000	CST	9139
p-Stat3(Tyr705)	R	H, M, R	1:1000	CST	9145
GLUT1	R	H, M, R	1:100	PT	21,829–1-AP

Abbreviations for the table: H, human; M, mouse; Rbt, rabbit; R, rat; CST, Cell Signaling Technology (Danvers, MA, USA). PT, Proteintech (Chicago, IL, USA). Abcam (Cambridge, MA, USA). MS, Mitoscience (St. Louis Park, MN, USA)

ISSN: 1756-9966